Meaning
Mandated asset sales required by antitrust regulators remove competitive overlaps to allow conditional merger approvals. A divestment remedy forces merging entities to sell specific business units or intellectual property rights to an independent third party. Regulatory agencies enforce these asset sales to preserve market competition and prevent post-merger monopoly power.
Approvals remain conditional until the divestiture completes under approved buyer qualification criteria.
Implementation Framework
Execution mandates require sellers to maintain divested assets as viable standalone businesses during negotiation periods. Implementing a divestment remedy involves appointing monitoring trustees who report asset operations directly to regulatory authorities. Sale agreements must satisfy strict agency standards regarding buyer independence and financial capability.
Failure to complete asset sales within statutory deadlines allows trustees to sell assets at fire-sale prices.
Carveout Complexity
Separating integrated operational assets creates severe execution challenges during corporate restructuring. Securing an approved divestment remedy requires transitional service agreements to maintain operational continuity for the purchaser. Shared intellectual property and centralized IT systems complicate clean asset separation.
Divestiture delays hold up main transaction closings across all involved jurisdictions.
Enforcement Limit
Regulators restrict asset sale mandates strictly to competitive overlaps identified during merger reviews. Overreaching divestment remedy orders face judicial review if structural commitments exceed necessary antitrust corrections.